What is 111 Inc (YI) stock price today?

111 Inc (YI) currently trades at $6.20 per share. The stock has a market capitalization of $59.37M and a P/E ratio of —x.

Is YI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, 111 Inc has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is —.

What is 111 Inc's revenue and earnings?

111 Inc has trailing twelve-month (TTM) revenue of $12.56B with profit margins of -0.53%. Earnings per share (EPS) is $-22.23.

Is 111 Inc financially healthy?

111 Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of — places it in the —.

111 Inc

NASDAQ: YI · HEALTHCARE · MEDICAL DISTRIBUTION

$6.20

-8.96% today

Updated 2026-04-30

Market cap

$59.37M

P/E ratio

—

P/S ratio

0.00x

EPS (TTM)

$-22.23

Dividend yield

—

52W range

$2 – $9

Volume

0.0M

Market cap

$59.37M

P/E ratio

—

P/S ratio

0.00x

EPS (TTM)

$-22.23

Dividend yield

—

52W range

$2 – $9

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

6.3

Quality

2.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.96

-3.87%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $38.08M — positive

+ Debt/equity -0.30x — low leverage

Risks

- Thin margins at -0.53%

- Revenue declining -26.70% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$13.52B	$14.95B	$14.40B	$12.21B	$12.56B
Net income	$-416.88M	$-392.69M	$-64.74M	$-16.84M	$-5.88M
EPS	—	—	—	—	$-22.23
Free cash flow	$-704.63M	$-54.73M	$-457.07M	$247.82M	$38.08M
Profit margin	-3.08%	-2.63%	-0.45%	-0.14%	-0.53%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
YI	$59.37M	21	2.7	2.0	5.0	6.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

111 Inc trades at $6.20. Our Smart Value Score of 21/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. TTM revenue stands at $12.56B. with profit margins at -0.53%.

Frequently asked questions

What is 111 Inc's stock price?

111 Inc (YI) trades at $6.20.

Is 111 Inc overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell).

What is the price target of 111 Inc (YI)?

The analyst target price is $5.96, representing -3.9% downside from the current price of $6.20.

What is 111 Inc's revenue?

TTM revenue is $12.56B.

Piotroski F-Score?

4/9 — moderate financial health.

Company info

SectorHEALTHCARE

IndustryMEDICAL DISTRIBUTION

CountryChina

ExchangeNASDAQ

CurrencyUSD

corporate.111.com.cn

Quick metrics

P/S ratio0.00x

ROE-7.57%

Beta0.70

50D MA$7.02

200D MA$5.67

Shares out0.01B

Float0.09B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

YI vs LLY →YI vs JNJ →YI vs ABBV →Stock screener →